Peixiang Wang Selected Research

polyglucosan

1/2022	Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
11/2020	GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease.
1/2019	Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.
8/2013	Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
7/2012	Phosphorylation prevents polyglucosan transport in Lafora disease.
12/2010	Glycogen hyperphosphorylation underlies lafora body formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peixiang Wang Research Topics

Disease

20	Lafora Disease 01/2023 - 12/2010
12	Epilepsy (Aura) 01/2023 - 07/2012
3	Adult Form Polyglucosan Body Disease 01/2022 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021 - 12/2015
2	Muscular Diseases (Myopathy) 01/2022 - 04/2009
2	Glycogen Storage Disease Type IV (Andersen's Disease) 01/2022 - 11/2020
2	Neuroinflammatory Diseases 11/2021 - 01/2021
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2023
1	Huntington Disease (Huntington's Disease) 10/2023
1	Disease Progression 01/2021
1	Gliosis 11/2020
1	Intellectual Disability (Idiocy) 04/2019
1	Glycogen Storage Disease (Glycogenosis) 01/2019
1	Neuroblastoma 01/2018
1	Dog Diseases (Disease, Canine) 01/2017
1	Guanidinoacetate methyltransferase deficiency 12/2015
1	Myoclonus (Nocturnal Myoclonus) 03/2014
1	Obesity 11/2013
1	Insulin Resistance 11/2013
1	Vacuolar myopathy 03/2013
1	Colonic Neoplasms (Colon Cancer) 06/2005
1	Polyps 06/2005
1	Carcinogenesis 10/2003
1	Carcinoma (Carcinomatosis) 10/2003
1	Breast Neoplasms (Breast Cancer) 10/2003

Drug/Important Bio-Agent (IBA)

18	GlycogenIBA 01/2023 - 12/2010
7	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2003
6	polyglucosanIBA 01/2022 - 12/2010
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 12/2010
3	Glycogen Synthase (Synthase I)IBA 01/2022 - 12/2010
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017 - 12/2010
2	EnzymesIBA 01/2022 - 09/2012
2	Messenger RNA (mRNA)IBA 11/2021 - 10/2003
2	UbiquitinIBA 01/2017 - 09/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 11/2013
1	Replication Protein AIBA 10/2023
1	Antisense OligonucleotidesIBA 11/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2021
1	CalciumIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	1,4-alpha-Glucan Branching Enzyme (Glycogen Branching Enzyme)IBA 11/2020
1	Glycoproteins (Glycoprotein)IBA 04/2019
1	A-Form DNA (A-DNA)IBA 01/2018
1	GhrelinIBA 01/2018
1	ElementsIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Everolimus FDA Link 02/2017
1	Guanidinoacetate N-Methyltransferase (Guanidinoacetate Methyltransferase)IBA 12/2015
1	Liver GlycogenIBA 11/2013
1	Insulin (Novolin)FDA Link 11/2013
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 03/2013
1	Ligases (Synthetase)IBA 09/2012
1	Phosphates (Orthophosphate)IBA 12/2010
1	Adenosine Triphosphatases (ATPase)IBA 04/2009
1	Proglucagon (Glucagon Precursors)IBA 06/2005
1	ColforsinIBA 06/2005
1	Transcription Factors (Transcription Factor)IBA 10/2003
1	TransferasesIBA 10/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2003
1	Homeodomain Proteins (Proteins, Homeobox)IBA 10/2003
1	Carrier Proteins (Binding Protein)IBA 10/2003

Therapy/Procedure

3	Therapeutics 11/2021 - 03/2014
1	Ketogenic Diet 12/2020
1	Euthanasia (Mercy Killing) 01/2018